MULTICENTRE, OPEN LABEL, RANDOMIZED, TWO-ARM, PARALLEL-GROUP STUDY TO ASSESS EFFICACY AND SAFETY OF ENVARSUS COMPARED WITH TACROLIMUS USED AS PER CURRENT CLINICAL PRACTICE IN THE INITIAL MAINTENANCE SETTING IN DE NOVO KIDNEY TRANSPLANT PATIENTS.
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms STEADY study
- Sponsors Chiesi Farmaceutici
- 10 Mar 2017 This trial has been completed in Austria - (end date: 2017-01-24).
- 08 Mar 2017 Status changed from active, no longer recruiting to completed.
- 07 Mar 2017 This trial has been completed in Belgium (end date: 2017-01-24).